This Viewpoint argues for adding a new category, targeting biomarkers, to the US Food and Drug Administration’s biomarker qualification framework.
This Viewpoint argues for adding a new category, targeting biomarkers, to the US Food and Drug Administration’s biomarker qualification framework.